Skip to main content
Caplight Logo









Shanghai Biotree Biomedical Technology Co., Ltd.

Shanghai Biotree Biomedical Technology Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://www.biotree.cn/

Last Round

Series A

Extension

Jan 3, 2023

Total Funding Raised

$16.29M

Company Overview

Shanghai Biotree Biomedical Technology Co., Ltd. is a biotechnology company that provides comprehensive metabolomics, proteomics, and multi-omics testing and analysis services for universities, research institutions, hospitals, and pharmaceutical enterprises.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

metabolomicsproteomicscontract research organizationCROmass spectrometryomics servicesmulti-omicslipidomicsbioinformaticslab servicesbiomarker discoverybiotech researchdrug discoveryprecision medicineclinical diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai Biotree Biomedical Technology Co., Ltd. Comparables

Compare Shanghai Biotree Biomedical Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Shanghai Biotree Biomedical Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shanghai Bioprofile Technology Co., Ltd.
93%
Shanghai Applied Protein Technology Co., Ltd.
92%
Metabo-Profile Biotechnology (Shanghai) Co., Ltd.
89%

Shanghai Biotree Biomedical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJan 3, 2023
Series AJul 15, 2022
Pre SeedMay 1, 2021
AngelAug 1, 2018

Shanghai Biotree Biomedical Technology Co., Ltd. Investors

Notable investors and investment history

Shanghai Biotree Biomedical Technology Co., Ltd. investors
InvestorRounds
Qiming Venture PartnersSeries A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 24, 2025

    Grew 125% QoQ, from 4 to 9 employees.

  • Jan 3, 2023

    $1.45M round led by Guangzhou Kingmed Diagnostics Group.

Shanghai Biotree Biomedical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanghai Biotree Biomedical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai Biotree Biomedical Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range9
Year Founded2013
Last FundingJan 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?